Tag: GSK

GSK advances in Hepatitis B cure with FDA’s fast track for bepirovirsen

businessnewstoday- February 13, 2024

In a significant development for the treatment of chronic hepatitis B (CHB), GSK plc (LSE/NYSE: GSK) has announced that the US Food and Drug Administration ... Read More

GSK seeks to extend shingles vaccine Shingrix to younger at-risk adults in China

businessnewstoday- February 7, 2024

GSK plc (LSE/NYSE: GSK) has reached a pivotal milestone in the prevention of shingles (herpes zoster) in China, with the Center for Drug Evaluation (CDE) ... Read More

GSK’s Blenrep shows significant efficacy in DREAMM-7 trial in multiple myeloma

businessnewstoday- February 7, 2024

GSK plc has unveiled promising results from the DREAMM-7 phase III trial, which highlights a notable advancement in the treatment of relapsed or refractory multiple ... Read More

EC grants approval for GSK’s Omjjara for treatment of myelofibrosis patients with anaemia

businessnewstoday- February 5, 2024

In a landmark decision, the European Commission has approved GSK plc's Omjjara (momelotinib), introducing a revolutionary treatment for adult myelofibrosis patients suffering from moderate to ... Read More

LIXTE Biotechnology commences Phase 1b/2 clinical trial in ovarian cancer

businessnewstoday- January 29, 2024

LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) has initiated a pivotal Phase 1b/2 clinical trial, in partnership with GSK, to evaluate the potential of ... Read More

GSK to acquire Aiolos Bio to expand respiratory treatment portfolio

businessnewstoday- January 9, 2024

GSK plc (LSE/NYSE: GSK) and Aiolos Bio, Inc. (Aiolos) have announced a significant agreement, where GSK will acquire Aiolos, a clinical-stage biopharmaceutical company focusing on ... Read More

GSK’s DREAMM-7 trial shows promising results for Blenrep in multiple myeloma

businessnewstoday- November 28, 2023

GSK plc has unveiled positive outcomes from the DREAMM-7 head-to-head phase III trial, evaluating Blenrep (belantamab mafodotin) as a treatment for relapsed or refractory multiple ... Read More

China’s shingles vaccine landscape revolutionized as GSK partners with Zhifei

businessnewstoday- October 14, 2023

Global pharmaceutical titan GSK plc is teaming up with Chongqing Zhifei Biological Products, Ltd. (Zhifei) - China's leading vaccine revenue generator - to co-promote its ... Read More

EC approves Cabotegravir LA by ViiV Healthcare for HIV prevention

businessnewstoday- September 19, 2023

ViiV Healthcare, majorly owned by GSK with Pfizer and Shionogi as shareholders, announced that the European Commission (EC) has authorized Apretude, also known as cabotegravir ... Read More

GSK to acquire Canadian biopharma company BELLUS Health for $2bn

businessnewstoday- April 23, 2023

GSK has agreed to acquire BELLUS Health, a Canadian biopharma company, in a deal worth around $2 billion in a move to further bolster its ... Read More